FDA NDC Directory · JSON-LD · Markdown

AMTAGVI

NDC 73776-001 · CELLULAR THERAPY · SUSPENSION

Generic namelifileucel
Labeler / ManufacturerIovance Biotherapeutics Inc.
Marketing categoryBiologic License Application · App BLA125773
Dosage form / routeSUSPENSION · INTRAVENOUS
Active ingredientsLIFILEUCEL (72000000000 1/500mL)
Marketing started20240216
Package count1

External sources

Source: openFDA. Public-domain (CC0).